Grigory L. Kozhemyakin

ParSynt-P converts a liquid-handling robot into a 96-parallel peptide synthesizer for generating peptide standards at a lower cost than custom synthesis.

This study uses plasma proteomics to differentiate benign and malignant thyroid nodules, identifying a classifier with adjustable specificity for clinical triage.

The paper assesses peptide proteotypicity in-house for targeted proteomics by synthesizing and verifying peptides from three plasma proteins.

The paper establishes a targeted method to assess plasma sample quality using hemolysis markers and proposes integrating hemolysis assessment into standard MRM analysis.